New 52 Week Low Today

Surface Oncology Inc SURF:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:15 PM EST
3.91quote price arrow down-0.02 (-0.51%)
Volume
1,905
Close
3.93quote price arrow down-0.08 (-2.00%)
Volume
537,408
52 week range
3.91 - 14.40
Loading...
  • Open4.13
  • Day High4.21
  • Day Low3.91
  • Prev Close4.01
  • 52 Week High14.40
  • 52 Week High Date01/21/21
  • 52 Week Low3.91
  • 52 Week Low Date01/20/22

Key Stats

  • Market Cap181.33M
  • Shares Out46.14M
  • 10 Day Average Volume0.62M
  • Dividend-
  • Dividend Yield-
  • Beta1.61
  • YTD % Change-17.78

KEY STATS

  • Open4.13
  • Day High4.21
  • Day Low3.91
  • Prev Close4.01
  • 52 Week High14.40
  • 52 Week High Date01/21/21
  • 52 Week Low3.91
  • 52 Week Low Date01/20/22
  • Market Cap181.33M
  • Shares Out46.14M
  • 10 Day Average Volume0.62M
  • Dividend-
  • Dividend Yield-
  • Beta1.61
  • YTD % Change-17.78

RATIOS/PROFITABILITY

  • EPS (TTM)0.07
  • P/E (TTM)56.63
  • Fwd P/E (NTM)-3.32
  • EBITDA (TTM)16.935M
  • ROE (TTM)11.89%
  • Revenue (TTM)90.10M
  • Gross Margin (TTM)-
  • Net Margin (TTM)14.33%
  • Debt To Equity (MRQ)10.81%

EVENTS

  • Earnings Date03/07/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Surface Oncology Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Surface Oncology, Inc. is a clinical-stage, immuno-oncology company focused on developing antibody therapies focused on the tumor microenvironment. The Company is developing multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable an immunologic response and enhance outcomes for patients with cancer. Its pipeline includes two wholly owned clinical-stage programs targeting CD39 (SRF617) and IL-27 (SRF388), as well as a...
Denice Torres J.D.
Chairman of the Board
Robert Ross M.D.
President, Chief Executive Officer, Director
Jessica Fees
Principal Financial Officer, Principal Accounting Officer, Senior Vice President, Finance, Treasurer
Address
50 Hampshire St Fl 8
Cambridge, MA
02139-1548
United States

Top Peers

SYMBOLLASTCHG%CHG
ADMA
ADMA Biologics Inc
1.43+0.01+0.70%
JNCE
Jounce Therapeutics Inc
6.01-0.25-3.99%
EOLS
Evolus Inc
5.54+0.25+4.73%
FBIO
Fortress Biotech Inc
2.10UNCHUNCH
CTMX
CytomX Therapeutics Inc
4.16+0.08+1.96%